Compare AU
Compare DRUG vs. TECH
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare Currency Hedged ETF (DRUG) and the Global X Morningstar Global Technology ETF (TECH). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | TECH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 59 | 180 |
Median incremental investment | $920.50 | $710.29 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,988.48 | $2,329.00 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | TECH | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | The Global X Morningstar Global Technology ETF (TECH: ASX) seeks to track the performance of the Morningstar Developed Markets Technology Moat Focus Index before considering any fees, expenses, or taxes. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | Sony Group Corp (4.32 %) Zscaler Inc (4.23 %) Vontier Corp Ordinary Shares (4.18 %) |
Top 3 industries | Other (75.15 %) Communication Services (33.53 %) Health Care (24.75 %) | Information Technology (49.31 %) Industrials (30.05 %) Consumer Discretionary (10.59 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | United States (76.16 %) Netherlands (7.48 %) Japan (5.55 %) |
Management fee | 0.57 % | 0.45 % |
Key Summary
DRUG | TECH | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | Morningstar Developed Markets Technology Moat Focus Index - USD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.45 % |
Price | $8.25 | $116.18 |
Size | $183.750 million | $376.962 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.89 % | 7.45 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 11/04/2017 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | TECH | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 59 | 180 |
Median incremental investment | $920.50 | $710.29 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,988.48 | $2,329.00 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | TECH | |
|---|---|---|
Pros |
| |
Cons |
|
DRUG | TECH |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |